The University of Texas MD Anderson Cancer Center Oncology Nursing Conference: Enhancing Knowledge, Transforming Practice

---

LIVE

Friday, September 25, 2026, 7:00 AM - Saturday, September 26, 2026, 4:30 PM, MD Anderson - Duncan Building, Houston, TX


ANCC - Nursing Contact Hour(s) (13.75 hours)

This program is designed to advance the field of oncology nursing by delivering comprehensive education across the continuum of care. It encompasses advanced practice topics, highlights best practices, fosters meaningful networking, and offers valuable insights from experienced clinical subject matter experts. With a strong emphasis on emerging drugs, innovative treatments, evolving processes, and the integration of translational research into clinical practice, the conference is tailored to meet the diverse needs of nurses working in all oncology settings. Grounded in current trends and the forefront of oncology practice, it provides a dynamic platform for learning, collaboration, and professional growth.

1. Describe current updates in oncology treatment and pharmacologic advances.
2. Explain evidence-based oncology management across the continuum of care for hematologic and solid tumors.
3. Define best practices for managing symptoms and comorbidities in the oncology population.

An In-Person + Virtual Activity 

The University of Texas MD Anderson Cancer Center Oncology Nursing Conference: Enhancing Knowledge, Transforming Practice will take place September 25–26, 2026, as a hybrid event offering both in-person and virtual attendance options. This year’s conference will feature expert-led sessions on emerging oncology treatments, precision medicine, nursing innovation, symptom management, and interdisciplinary best practices designed to support oncology nurses across all care settings. The conference will begin at 8:00 AM on Friday, September 25, 2026. 

Advanced registration is encouraged. The deadline for advanced registration is August 25, 2026.

Registration Category	Before Aug. 25	On or After Aug. 25
MDA/Cancer Network Employees	$100	$125
MDA/Cancer Network – Virtual	$135	$155
Non-MDA/Cancer Network Employee	$150	$175
Non-MDA/Cancer Network Employee – Virtual	$185	$200
Students/Trainees	$25	$35
Students/Trainees – Virtual	$35	$45

Telephone registrations are not accepted.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check (payable through U.S. banks only)

• Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

Virtual Registration: Once your payment has been made, a receipt can be found in the MyCE area of your PEP@MD Anderson account. The Zoom information and all other necessary links will be emailed out the week of the conference. The virtual conference will be streamed live via Zoom.

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

REFUND/CANCELLATION POLICY
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before, August 25, 2026.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or by phone given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance or Additional Information
Contact Continuing Professional Education / Activity Management at 713-792-2223 or 866-849-5866. You may also email CPE at [email protected].  

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. 

 

 

ACCME Statement
In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Statement:
The University of Texas MD Anderson Cancer Center designates this live activity will award 13.75 Nursing Contact Hour(s).

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.